The formation of platelet–leukocyte aggregates varies during the menstrual cycle

References

• Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Variation in the risk of onset of acute myocardial infarction during the menstrual cycle. Am J Cardiol 2002; 90: 49–51
   PubMedGoogle Scholar
• Lahita RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 951–968
   PubMed Web of Science ®Google Scholar
• Freedman JE, Loscalzo J. Platelet-monocyte aggregates: Bridging thrombosis and inflammation. Circulation 2002; 105: 2130–2132
   PubMed Web of Science ®Google Scholar
• Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999; 106: 391–399
   PubMed Web of Science ®Google Scholar
• Silverstein RL, Nachman RL. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest 1987; 79: 867–874
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Motomiya T, Kikutani N, Sakakibara C, Watanabe S, Numata M, Noguchi K. Platelet aggregation during menstrual cycle and pregnancy. Thromb Res 1979; 14: 333–340
   PubMed Web of Science ®Google Scholar
• Markham SM, Dubin NH, Rock JA. The effect of the menstrual cycle and of decompression stress on arachidonic acid-induced platelet aggregation and on intrinsic platelet thromboxane production in women compared with men. Am J Obstet Gynecol 1991; 165: 1821–1829
   PubMedGoogle Scholar
• Zahavi J, Dreyfuss F, Kalef M, Soferman N. Adenosine diphosphate-induced platelet aggregation in healthy women with and without a combined and sequential contraceptive pill. Am J Obstet Gynecol 1973; 117: 107–113
   PubMedGoogle Scholar
• Pedersen OS, Reichelt KL. Increased calcium response to ADP in blood platelets from women during ovulation compared with menstruation: Cytoplasmic calcium measured with the fura-2 technique. Acta Physiol Scand 1988; 132: 335–339
   PubMedGoogle Scholar
• Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533–1537
   PubMed Web of Science ®Google Scholar
• Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol 2001; 66: 143–151
   PubMed Web of Science ®Google Scholar
• Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996; 94: 1239–1246
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877–11882
   PubMed Web of Science ®Google Scholar
• Rohrer MJ, Claytor RB, Garnette CS, Powell CC, Barnard MR, Furman MI, Michelson AD. Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of reflux. Cardiovasc Surg 2002; 10: 464–469
   PubMedGoogle Scholar
• Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leukocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001; 115: 451–459
   PubMed Web of Science ®Google Scholar
• Li N, Goodall AH, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leukocyte aggregates. Br J Haematol 1997; 99: 808–816
   PubMed Web of Science ®Google Scholar
• Li N, Goodall AH, Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999; 35: 154–161
   PubMedGoogle Scholar
• Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb/IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107–11114
   PubMed Web of Science ®Google Scholar
• Larsen LF, Andersen HR, Hansen AB, Andersen O. Variation in risk indicators of cardiovascular disease during the menstrual cycle: An investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women. Scand J Clin Lab Invest 1996; 56: 241–249
   PubMed Web of Science ®Google Scholar
• Faraday N, Goldschmidt-Clermont PJ, Bray PF. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost 1997; 77: 748–754
   PubMed Web of Science ®Google Scholar
• Feuring M, Christ M, Roell A, Schueller P, Losel R, Dempfle CE, Schultz A, Wehling M. Alterations in platelet function during the ovarian cycle. Blood Coagul Fibrinolysis 2002; 13: 443–447
   PubMed Web of Science ®Google Scholar
• Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: Effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82: 1456–1461
   PubMed Web of Science ®Google Scholar
• Nealen ML, Vijayan KV, Bolton E, Bray PF. Human platelets contain a glycosylated estrogen receptor beta. Circ Res 2001; 88: 438–442
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Miller VM. Human platelets contain estrogen receptor α, caveolin-1 and estrogen receptor associated proteins. Platelets 2003; 14: 75–81
   PubMed Web of Science ®Google Scholar
• Moro L, Reineri S, Piranda D, Pietrapiana D, Lova P, Bertoni A, Graziani A, Defilippi P, Canobbio I, Torti M, Sinigaglia F. Nongenomic effects of 17beta-estradiol in human platelets: Potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase. Blood 2005; 105: 115–121
   PubMed Web of Science ®Google Scholar
• Nakano Y, Oshima T, Ozono R, Ueda A, Oue Y, Matsuura H, Sanada M, Ohama K, Chayama K, Kambe M. Estrogen replacement suppresses function of thrombin stimulated platelets by inhibiting Ca(2+) influx and raising cyclic adenosine monophosphate. Cardiovasc Res 2002; 53: 634–641
   PubMedGoogle Scholar
• Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med 2001; 125: 112–115
   PubMed Web of Science ®Google Scholar
• Nakano Y, Oshima T, Matsuura H, Kajiyama G, Kambe M. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler Thromb Vasc Biol 1998; 18: 961–967
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). J Am Med Assoc 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar